Computing the Social Brain Connectome Across Systems and States
Alcalá-López, Daniel, Smallwood, Jonathan, Jefferies, Elizabeth, Van Overwalle, Frank, Vogeley, Kai, Mars, Rogier B, Turetsky, Bruce I, Laird, Angela R, Fox, Peter T, Eickhoff, Simon B, Bzdok, Danilo
Published in Cerebral cortex (New York, N.Y. 1991) (01.07.2018)
Published in Cerebral cortex (New York, N.Y. 1991) (01.07.2018)
Get full text
Journal Article
Building blocks of social cognition: Mirror, mentalize, share?
Alcalá-López, Daniel, Vogeley, Kai, Binkofski, Ferdinand, Bzdok, Danilo
Published in Cortex (01.09.2019)
Published in Cortex (01.09.2019)
Get full text
Journal Article
Brain-wide representation of social knowledge
Alcalá-López, Daniel, Mei, Ning, Margolles, Pedro, Soto, David
Published in Social cognitive and affective neuroscience (13.06.2024)
Published in Social cognitive and affective neuroscience (13.06.2024)
Get full text
Journal Article
A single-arm study design with non-inferiority and superiority time-to-event endpoints: a tool for proof-of-concept and de-intensification strategies in breast cancer
Sampayo-Cordero, Miguel, Miguel-Huguet, Bernat, Malfettone, Andrea, López-Miranda, Elena, Gion, María, Abad, Elena, Alcalá-López, Daniel, Pérez-Escuredo, Jhudit, Pérez-García, José Manuel, Llombart-Cussac, Antonio, Cortés, Javier
Published in Frontiers in oncology (11.07.2023)
Published in Frontiers in oncology (11.07.2023)
Get full text
Journal Article
Challenging Endocrine Sensitivity of Hormone Receptor-Positive/HER2-Negative Advanced Breast Cancer with the Combination of Eribulin and Endocrine Therapy: The REVERT Study
López González, Ana, Del Barco Berrón, Sonia, Grau, Isabel, Galan, Maria, Castelo Fernández, Beatriz, Cortés, Alfonso, Sánchez Rovira, Pedro, Martinez-Bueno, Alejandro, Gonzalez, Xavier, García, Almudena, Gener, Petra, Mina, Leonardo, Alcalá-López, Daniel, Sampayo, Miguel, Cortés, Javier, Pérez-Garcia, José Manuel, Llombart-Cussac, Antonio, López-Miranda, Elena
Published in Cancers (29.11.2022)
Published in Cancers (29.11.2022)
Get full text
Journal Article
Phase II study of the efficacy of retifanlimab (Rf) (INCMGA00012) in penile squamous cell carcinoma (PSqCC): ORPHEUS final analysis
Garcia del Muro, Xavier, Cuellar, M. Andres, Maroto-Rey, Pablo, Giannatempo, Patrizia, Castellano, Daniel, Necchi, Andrea, Climent, Miguel Ángel, Valderrama, Begoña Pérez, Gomez De Liano Lista, Alfonso, Molina, David, Mina, Leonardo, Alcalá-López, Daniel, Sampayo, Miguel, Paez, David
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
3-year invasive disease-free survival with chemotherapy de-escalation using an 18 F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast cancer (PHERGain): a randomised, open-label, phase 2 trial
Pérez-García, José Manuel, Cortés, Javier, Ruiz-Borrego, Manuel, Colleoni, Marco, Stradella, Agostina, Bermejo, Begoña, Dalenc, Florence, Escrivá-de-Romaní, Santiago, Calvo Martínez, Lourdes, Ribelles, Nuria, Marmé, Frederik, Cortés, Alfonso, Albacar, Cinta, Gebhart, Geraldine, Prat, Aleix, Kerrou, Khaldoun, Schmid, Peter, Braga, Sofia, Di Cosimo, Serena, Gion, Maria, Antonarelli, Gabriele, Popa, Crina, Szostak, Emilia, Alcalá-López, Daniel, Gener, Petra, Rodríguez-Morató, Jose, Mina, Leonardo, Sampayo-Cordero, Miguel, Llombart-Cussac, Antonio
Published in The Lancet (British edition) (27.04.2024)
Published in The Lancet (British edition) (27.04.2024)
Get full text
Journal Article
3-year invasive disease-free survival (iDFS) of the strategy-based, randomized phase II PHERGain trial evaluating chemotherapy (CT) de-escalation in human epidermal growth factor receptor 2-positive (HER2[+]) early breast cancer (EBC)
Cortes, Javier, Pérez-García, José Manuel, Ruiz-Borrego, Manuel, Stradella, Agostina, Bermejo, Begona, Escrivá-de-Romaní, Santiago, Calvo Martínez, Lourdes, Ribelles, Nuria, Cortés Salgado, Alfonso, Albacar, Cinta, Colleoni, Marco, Gebhart, Geraldine, Prat, Aleix, Khaldoun, Kerrou, Schmid, Peter, Di Cosimo, Serena, Popa, Crina, Alcalá-López, Daniel, Sampayo-Cordero, Miguel, Llombart-Cussac, Antonio
Published in Journal of clinical oncology (10.06.2023)
Published in Journal of clinical oncology (10.06.2023)
Get full text
Journal Article
Second-line endocrine therapy (ET) with or without palbociclib (P) maintenance in patients (pts) with hormone receptor-positive (HR[+])/human epidermal growth factor receptor 2-negative (HER2[-]) advanced breast cancer (ABC): PALMIRA trial
Llombart-Cussac, Antonio, Harper-Wynne, Catherine, Perello, Antonia, Hennequin, Audrey, Fernandez, Adela, Colleoni, Marco, Carañana, Vicente, Quiroga, Vanesa, Medioni, Jacques, Iranzo, Vega, Wheatley, Duncan, Del Barco, Sonia, Anton, Antonio, Dobi, Erion, Ruiz-Borrego, Manuel, Alcalá-López, Daniel, Pérez-Escuredo, Jhudit, Sampayo-Cordero, Miguel, Pérez-García, José Manuel, Cortes, Javier
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Abstract PO1-20-02: MiRaDor: A proof-of-concept study of treatment efficacy by monitoring Minimal Residual Disease (MRD) using circulating tumor DNA (ctDNA) in hormone receptor-positive/HER2-negative (HR+/HER2-) early breast cancer (EBC)
Llombart-Cussac, Antonio, Pérez-García, José Manuel, Gion, María, Alcalá-López, Daniel, Fazal-Salom, Janet, Lazaris, Alexandros, Mancino, Mario, Shimizu, Eileen, Victorino, Susana, Zhang, Rui Rui, Machackova, Zuzana, Schimmoller, Frauke, Wongchenko, Matthew, Gligorov, Joseph, Schmid, Peter, Cortés, Javier
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Get full text
Journal Article
The DEBBRAH trial: Trastuzumab deruxtecan in HER2-positive and HER2-low breast cancer patients with leptomeningeal carcinomatosis
Vaz Batista, Marta, Pérez-García, José Manuel, Garrigós, Laia, García-Sáenz, José Ángel, Cortez, Patricia, Racca, Fabricio, Blanch, Salvador, Ruiz-Borrego, Manuel, Fernández-Ortega, Adela, Fernández-Abad, María, Iranzo, Vega, Gion, María, Martrat, Griselda, Alcalá-López, Daniel, Pérez-Escuredo, Jhudit, Sampayo-Cordero, Miguel, Llombart-Cussac, Antonio, Braga, Sofia, Cortés, Javier
Published in Med (New York, N.Y. : Online) (04.09.2024)
Published in Med (New York, N.Y. : Online) (04.09.2024)
Get full text
Journal Article
OCTS-03 A MULTICENTER, OPEN-LABEL, SINGLE-ARM, MULTICOHORT PHASE II CLINICAL TRIAL OF TRASTUZUMAB DERUXTECAN IN HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 (HER2)-POSITIVE AND HER2-LOW ADVANCED BREAST CANCER (ABC) WITH BRAIN METASTASES AND/OR LEPTOMENINGEAL CARCINOMATOSIS (LMC) – THE DEBBRAH STUDY
Vaz-Batista, Marta, Pérez-García, José Manuel, Cortez, Patricia, Garrigós, Laia, Ruiz-Borrego, Manuel, de la Haba-Rodríguez, Juan, de las Heras, Begoña Bermejo, Servitja, Sonia, Racca, Fabricio, Fernández-Abad, María, Blanch, Salvador, Teurel, Iris, Sáenz1, Jose Ángel Garcia, Ortega, Adela Fernandez, Martrat, Griselda, Shimizu, Eileen, Alcalá-López, Daniel, Pérez-Escuredo, Jhudit, Braga, Sofia, Llombart-Cussac, Antonio, Cortes, Javier
Published in Neuro-oncology advances (02.08.2024)
Published in Neuro-oncology advances (02.08.2024)
Get full text
Journal Article
Retifanlimab in Advanced Penile Squamous Cell Carcinoma: The Phase 2 ORPHEUS Study
García Del Muro, Xavier, Páez López-Bravo, David, Cuéllar-Rivas, Miler Andrés, Maroto, Pablo, Giannatempo, Patrizia, Castellano, Daniel, Climent, Miguel A., Valderrama, Begoña P., Gómez de Liaño, Alfonso, López-Montero, Laura, Mina, Leonardo, Alcalá-López, Daniel, Sampayo-Cordero, Miguel, Necchi, Andrea
Published in European urology oncology (14.05.2024)
Published in European urology oncology (14.05.2024)
Get full text
Journal Article
Abstract PS11-05: Trastuzumab Deruxtecan in patients with HER2[+] or HER2-Low Advanced Breast Cancer and Pathologically Confirmed Leptomeningeal Carcinomatosis: Results from Cohort 5 of the DEBBRAH Study
Batista, Marta Vaz, Pérez-García, José Manuel, Garrigós, Laia, García-Sáenz, José Ángel, Cortez-Castedo, Patricia, Racca, Fabriccio, Blanch, Salvador, Ruíz - Borrego, Manuel, Fernández, Adela, Fernández-Abad, María, Iranzo, Vega, Gion, Maria, Martrat, Griselda, Alcalá-López, Daniel, Pérez-Escuredo, Jhudit, Sampayo-Cordero, Miguel, Llombart-Cussac, Antonio, Braga, Sofía, Cortés, Javier
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Get full text
Journal Article
Abstract PS16-02: Efficacy and safety of first-line atezolizumab + bevacizumab + paclitaxel in patients with advanced triple-negative breast cancer: the ATRACTIB phase 2 trial
Gion, Maria, Cortez-Castedo, Patricia, Blancas, Isabel, Cortés, Alfonso, Marmé, Frederik, Blanch, Salvador, Murillo, Serafin Morales, Díaz, Nieves, Calvo-Plaza, Isabel, Recalde, Sabela, Martínez-Bueno, Alejandro, Ruiz-Borrego, Manuel, Llabres, Elisenda, Taberner, María Teresa, de Laurentiis, Michelino, García-Sáenz, José Ángel, Repkova, Jana, Antón, Antonio, Gligorov, Joseph, Cruz, Susana de la, Hoffmann, Oliver, Medioni, Jacques, Phillips, Melissa, Sampayo-Cordero, Miguel, Alcalá-López, Daniel, Pérez-García, José Manuel, Llombart-Cussac, Antonio, Cortés, Javier
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Get full text
Journal Article
Preventing alpelisib-related hyperglycaemia in HR+/HER2−/PIK3CA-mutated advanced breast cancer using metformin (METALLICA): a multicentre, open-label, single-arm, phase 2 trialResearch in context
Antonio Llombart-Cussac, José Manuel Pérez-Garcia, Manuel Ruiz Borrego, Pablo Tolosa, Salvador Blanch, Adela Fernández-Ortega, Ander Urruticoechea, Isabel Blancas, Cristina Saura, Beatriz Rojas, Begoña Bermejo, José Ponce Lorenzo, María Gion, Patricia Cortez-Castedo, Elisenda Llabres, Elena Galve, Juan Fernando Cueva, Ana López, José Luis Alonso-Romero, Santiago González-Santiago, Eduardo Martínez de Dueñas, Eva Ciruelos, Griselda Martrat, Petra Gener, Daniel Alcalá-López, Miguel Sampayo-Cordero, Fernando Gómez-Peralta, Javier Cortés
Published in EClinicalMedicine (01.05.2024)
Get full text
Published in EClinicalMedicine (01.05.2024)
Journal Article
3-year invasive disease-free survival with chemotherapy de-escalation using an 18F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast cancer (PHERGain): a randomised, open-label, phase 2 trial
Pérez-García, José Manuel, Cortés, Javier, Ruiz-Borrego, Manuel, Colleoni, Marco, Stradella, Agostina, Bermejo, Begoña, Dalenc, Florence, Escrivá-de-Romaní, Santiago, Calvo Martínez, Lourdes, Ribelles, Nuria, Marmé, Frederik, Cortés, Alfonso, Albacar, Cinta, Gebhart, Geraldine, Prat, Aleix, Kerrou, Khaldoun, Schmid, Peter, Braga, Sofia, Di Cosimo, Serena, Gion, Maria, Antonarelli, Gabriele, Popa, Crina, Szostak, Emilia, Alcalá-López, Daniel, Gener, Petra, Rodríguez-Morató, Jose, Mina, Leonardo, Sampayo-Cordero, Miguel, Llombart-Cussac, Antonio
Published in The Lancet (British edition) (27.04.2024)
Published in The Lancet (British edition) (27.04.2024)
Get full text
Journal Article
Preventing alpelisib-related hyperglycaemia in HR+/HER2−/PIK3CA-mutated advanced breast cancer using metformin (METALLICA): a multicentre, open-label, single-arm, phase 2 trial
Llombart-Cussac, Antonio, Pérez-Garcia, José Manuel, Ruiz Borrego, Manuel, Tolosa, Pablo, Blanch, Salvador, Fernández-Ortega, Adela, Urruticoechea, Ander, Blancas, Isabel, Saura, Cristina, Rojas, Beatriz, Bermejo, Begoña, Ponce Lorenzo, José, Gion, María, Cortez-Castedo, Patricia, Llabres, Elisenda, Galve, Elena, Cueva, Juan Fernando, López, Ana, Alonso-Romero, José Luis, González-Santiago, Santiago, Martínez de Dueñas, Eduardo, Ciruelos, Eva, Martrat, Griselda, Gener, Petra, Alcalá-López, Daniel, Sampayo-Cordero, Miguel, Gómez-Peralta, Fernando, Cortés, Javier
Published in EClinicalMedicine (01.05.2024)
Published in EClinicalMedicine (01.05.2024)
Get full text
Journal Article